These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 23679077)

  • 1. Oxymetazoline and hypertensive crisis in a child: can we prevent it?
    Latham GJ; Jardine DS
    Paediatr Anaesth; 2013 Oct; 23(10):952-6. PubMed ID: 23679077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical Nasal Decongestant Oxymetazoline: Safety Considerations for Perioperative Pediatric Use.
    Cartabuke R; Tobias JD; Jatana KR;
    Pediatrics; 2021 Nov; 148(5):. PubMed ID: 34607935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thunderclap headache and reversible segmental cerebral vasoconstriction associated with use of oxymetazoline nasal spray.
    Loewen AH; Hudon ME; Hill MD
    CMAJ; 2004 Sep; 171(6):593-4. PubMed ID: 15367461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal Medication Administration Using a Squeeze Bottle Atomizer Results in Overdosing if Deployed in Supine Patients.
    Goldhammer JE; Dobish MA; McAnulty JT; Smaka TJ; Epstein RH
    Anesth Analg; 2017 Aug; 125(2):453-457. PubMed ID: 27828797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxymetazoline nasal spray three times daily for four weeks in normal subjects is not associated with rebound congestion or tachyphylaxis.
    Watanabe H; Foo TH; Djazaeri B; Duncombe P; Mackay IS; Durham SR
    Rhinology; 2003 Sep; 41(3):167-74. PubMed ID: 14579657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute coronary syndrome after nasal spray of oxymetazoline.
    Montastruc F; Montastruc G; Taudou MJ; Olivier-Abbal P; Montastruc JL; Bondon-Guitton E
    Chest; 2014 Dec; 146(6):e214-e215. PubMed ID: 25451367
    [No Abstract]   [Full Text] [Related]  

  • 7. Double-masked, randomized, placebo-controlled study to evaluate the efficacy and tolerability of intranasal K305 (3% tetracaine plus 0.05% oxymetazoline) in anesthetizing maxillary teeth.
    Hersh EV; Pinto A; Saraghi M; Saleh N; Pulaski L; Gordon SM; Barnes D; Kaplowitz G; Bloom I; Sabti M; Moore PA; Lee S; Meharry M; He DY; Li Y
    J Am Dent Assoc; 2016 Apr; 147(4):278-87. PubMed ID: 26822100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxymetazoline Metered Dose Spray: Factors Affecting Delivery Volume.
    Hakim M; Walia H; Rafiq M; Grannell T; Cartabuke RS; Tobias JD
    J Pediatr Pharmacol Ther; 2016; 21(3):247-51. PubMed ID: 27453703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxymetazoline adds to the effectiveness of fluticasone furoate in the treatment of perennial allergic rhinitis.
    Baroody FM; Brown D; Gavanescu L; DeTineo M; Naclerio RM
    J Allergy Clin Immunol; 2011 Apr; 127(4):927-34. PubMed ID: 21377716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Not Just a Drop in the Bucket-Inversion of Oxymetazoline Nasal Decongestant Container Increases Potential for Severe Pediatric Poisoning.
    Nordt SP; Vivero LE; Cantrell FL
    J Pediatr; 2016 Jan; 168():240-241. PubMed ID: 26522979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ["Of snakes and crocodiles": central side effects of nose drops and facts about rhinitis medicamentosa].
    Bielenberg J
    Kinderkrankenschwester; 2011 Oct; 30(10):406-8. PubMed ID: 22029138
    [No Abstract]   [Full Text] [Related]  

  • 12. [Tolerance and effectiveness of oxymetazoline and xylometazoline in treatment of acute rhinitis].
    Dorn M; Hofmann W; Knick E
    HNO; 2003 Oct; 51(10):794-9. PubMed ID: 14523532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of sustained-release oral phenylpropanolamine on the nasal mucosa of healthy subjects.
    Graf P; Toll K; Palm J; Hallén H
    Acta Otolaryngol; 1999; 119(7):837-42. PubMed ID: 10687944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-ST-elevation myocardial infarction with the use of oxymetazoline nasal spray.
    Rajpal S; Morris LA; Akkus NI
    Rev Port Cardiol; 2014 Jan; 33(1):51.e1-4. PubMed ID: 24405558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal corticosteroid and oxymetazoline for chronic rhinitis: a systematic review.
    Neighbors CL; Salvador CF; Zhu B; Camacho M; Tsai P
    J Laryngol Otol; 2022 Jan; 136(1):8-16. PubMed ID: 34702392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of 0.05% oxymetazoline (Vicks Sinex Micromist®) nasal spray in the treatment of objective nasal congestion demonstrated to 12 h post-administration by magnetic resonance imaging.
    Pritchard S; Glover M; Guthrie G; Brum J; Ramsey D; Kappler G; Thomas P; Stuart S; Hull D; Gowland P
    Pulm Pharmacol Ther; 2014 Feb; 27(1):121-6. PubMed ID: 23988443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paranasal sinusitis after long-term use of topical nasal decongestants.
    Min YG; Kim HS; Suh SH; Jeon SY; Son YI; Yoon S
    Acta Otolaryngol; 1996 May; 116(3):465-71. PubMed ID: 8790749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The use of oxymetazoline in nasal endoscopic sinus surgery].
    Zhen H; Gao Q; Cui Y; Hua X; Li H; Feng J
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 May; 17(5):281-2. PubMed ID: 12916356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative evaluation of nasal blood flow and airflow in the decongestant response to oxymetazoline.
    Vaidyanathan S; Williamson P; Lipworth B
    Ann Allergy Asthma Immunol; 2012 Feb; 108(2):77-80. PubMed ID: 22289724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxymetazoline nasal spray.
    Graf P
    Laryngoscope; 1998 Aug; 108(8 Pt 1):1255. PubMed ID: 9707257
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.